QuicKfire

AUT00063 · Autifony Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QuicKfire, covering 2017-05-24 to 2017-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating Possible Improvement in Speech and Hearing Tests After 28 Days of Dosing of the Study Drug AUT00063 Compared to Placebo (QuicKfire) [Phase 2]

See pricing